Classic, an Earnings conference call yet the earnings/losses are never mentioned....
It's going to be fun observing how many hundreds of millions of MDBX common shares were issued to the Class Action Lawsuit Plaintiffs in the settlement...this should have been disclosed by MDBX earlier...
oops, wait a minute, that is not what criminal enterprises like MDBX do...
so now we wait until disclosure in the 10Q when it is ever filed with the SEC
10-Q will be filed later this week .
As expected, for the third quarter ending September 30, 2015, the Company again registered a large loss from operation. The vast majority of which consisted of non-cash stock-based compensation expense, along with legal and professional costs primarily associated with our second Form S-1 filing to raise additional capital and our 14-C filing to increase the number of authorized shares of common stock. We also posted $289,000 in revenues for the quarter, significantly up from $84,000 in the preceding second quarter and $148,000 last year. About half the revenues came from consulting fees and contributions from our Vaporfection subsidiary, along with some one-time non-recurring amounts.